Long-Term Safety, Clinical and Immunological Outcomes in Primary Membranous Nephropathy with Severe Renal Impairment Treated with Cyclophosphamide and Steroid-Based Regimen.

Data from long-term trials using different ImS regimens for patients with an eGFR of >30 mL/min/1.73 m 2 showed a trend toward preserved renal function and achieving a state of remission over years of follow-up [ 15 , 20 ].

also in 53,322 other papers